Literature DB >> 12909313

Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression.

Katare Gopalrao Rajesh1, Shiro Sasaguri, Zou Zhitian, Ryoko Suzuki, Rei Asakai, Hironori Maeda.   

Abstract

OBJECTIVE: The second window of protection (SWOP) following brief coronary artery occlusion begins at 24 h and may last up to 72 h and occurs via many unknown mechanisms. We investigated the role of the mitochondrial permeability transition pore (PTP), a non specific pore in the inner membrane of the mitochondria in this phenomenon.
METHODS: Ischemic preconditioning (IP) was induced in Wistar rats by left coronary artery occlusion (four, 3-min episodes separated by 10 min of reperfusion) on day 1. On day 2, ischemia was induced with 30 min of ischemia and 120 min of reperfusion in IP and control rats.
RESULTS: IP rats showed decreased myocardial infarction (MI) area vs. non-IP control rats (15.32 vs. 45.6%). Furthermore, IP rats had preserved cardiac function (heart rate, rate pressure product, coronary flow and aortic flow) and myocardial ATP (P<0.03), decreased tissue water content (73.2 vs. 90.6%), increased expression of Bcl-2, and less mitochondrial swelling, cytochrome C release and apoptosis (2.6 vs. 12.4%) when compared to sham-operated rats. Activation of the permeability transition pore with PTP activators lonidamine (10 mg/kg body weight) or atractyloside (5 mg/kg body weight) before the sustained ischemia on day 2 resulted in complete abolition of SWOP-mediated cytoprotective effects. These agents had no effect on the cytoprotective effects that took place during the first window of preconditioning.
CONCLUSION: The cytoprotective effects of SWOP are dependent on PTP activation state and may involve upregulation of Bcl-2 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909313     DOI: 10.1016/s0008-6363(03)00358-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Altered expression of mitochondrial electron transport chain proteins and improved myocardial energetic state during late ischemic preconditioning.

Authors:  Jesús A Cabrera; Elizabeth A Ziemba; Robert Colbert; Lorraine B Anderson; Willem Sluiter; Dirk J Duncker; Tammy A Butterick; Joseph Sikora; Herbert B Ward; Rosemary F Kelly; Edward O McFalls
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-02       Impact factor: 4.733

2.  Intestinal microbiota determine severity of myocardial infarction in rats.

Authors:  Vy Lam; Jidong Su; Stacy Koprowski; Anna Hsu; James S Tweddell; Parvaneh Rafiee; Garrett J Gross; Nita H Salzman; John E Baker
Journal:  FASEB J       Date:  2012-01-12       Impact factor: 5.191

3.  Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.

Authors:  Xian-Liang Tang; Yu-Ting Xuan; Yanqing Zhu; Gregg Shirk; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-18       Impact factor: 4.733

Review 4.  Stem cell therapy: pieces of the puzzle.

Authors:  John A Schoenhard; Antonis K Hatzopoulos
Journal:  J Cardiovasc Transl Res       Date:  2009-11-19       Impact factor: 4.132

5.  Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.

Authors:  Rajesh G Katare; Motonori Ando; Yoshihiko Kakinuma; Takayuki Sato
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

6.  Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

Authors:  Radha Ananthakrishnan; Michiyo Kaneko; Yuying C Hwang; Nosirudeen Quadri; Teodoro Gomez; Qing Li; Casper Caspersen; Ravichandran Ramasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

7.  Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms.

Authors:  Alfred C Nicolosi; Jennifer L Strande; Anna Hsu; Xiangping Fu; Jidong Su; Garrett J Gross; John E Baker
Journal:  J Mol Cell Cardiol       Date:  2007-11-19       Impact factor: 5.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.